老年非小細胞肺癌患者術(shù)后生存期的影響因素
發(fā)布時間:2018-09-06 13:02
【摘要】:目的分析老年非小細胞肺癌患者術(shù)后生存期的影響因素。方法選擇非小細胞肺癌患者90例,收集患者的年齡、性別、基礎(chǔ)疾病、臨床癥狀、術(shù)后并發(fā)癥、術(shù)后體力狀況(ECOG)評分、病理分期、病理類型、手術(shù)方式、隨訪資料等相關(guān)臨床資料。結(jié)果 90例患者中失訪8例,失訪率為8.9%,術(shù)后1年生存率為71.1%,術(shù)后3年的生存率為62.2%,術(shù)后5年的生存率為41.1%,中位生存期為43個月。生存期影響因素的單因素分析結(jié)果顯示:有臨床癥狀者、術(shù)后有并發(fā)癥者、ECOG評分2~4分者、病理分期Ⅲa期者、全肺切除術(shù)者的生存時間短(P0.05);年齡、性別、病理類型對患者術(shù)后生存期沒有明顯影響(P0.05)。COX回歸分析結(jié)果顯示:ECOG評分和病理分期是老年非小細胞肺癌患者術(shù)后生存期的獨立影響因素(P0.05)。結(jié)論 ECOG評分和病理分期是老年非小細胞肺癌患者術(shù)后生存期的獨立影響因素,術(shù)后體力狀態(tài)好、病理分期早的患者術(shù)后生存期比較長。
[Abstract]:Objective to analyze the influencing factors of postoperative survival in elderly patients with non-small cell lung cancer (NSCLC). Methods 90 patients with non-small cell lung cancer were selected and their age, sex, basic diseases, clinical symptoms, postoperative complications, (ECOG) score of postoperative physical strength, pathological staging, pathological types, and operation methods were collected. Follow-up data and other related clinical data. Results among the 90 patients, 8 cases lost the visit, the missing rate was 8.9%, the 1 year survival rate was 71. 1%, the 3 year survival rate was 62. 2%, the 5 year survival rate was 41. 1%, the median survival time was 43 months. The results of univariate analysis showed that the survival time of patients with clinical symptoms, postoperative complications, pathological stage 鈪,
本文編號:2226429
[Abstract]:Objective to analyze the influencing factors of postoperative survival in elderly patients with non-small cell lung cancer (NSCLC). Methods 90 patients with non-small cell lung cancer were selected and their age, sex, basic diseases, clinical symptoms, postoperative complications, (ECOG) score of postoperative physical strength, pathological staging, pathological types, and operation methods were collected. Follow-up data and other related clinical data. Results among the 90 patients, 8 cases lost the visit, the missing rate was 8.9%, the 1 year survival rate was 71. 1%, the 3 year survival rate was 62. 2%, the 5 year survival rate was 41. 1%, the median survival time was 43 months. The results of univariate analysis showed that the survival time of patients with clinical symptoms, postoperative complications, pathological stage 鈪,
本文編號:2226429
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2226429.html
最近更新
教材專著